Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928
The Tumor Microenvironment02:17

The Tumor Microenvironment

7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

506
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
506
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell-free therapy for alopecia via the secretome of hiPSC-derived dermal papilla cells.

Journal of tissue engineering·2026
Same author

OncoCorridor: connecting patients with cancer in conflict zones to treatment centres worldwide.

The Lancet. Oncology·2026
Same author

Immunotherapy Response and Survival Outcome by Immunophenotypic Signature in Non-Small Cell Lung Cancer.

JCO precision oncology·2026
Same author

The Molecular Landscape of CASTLE: A Rare Thymus-like Head and Neck Cancer.

International journal of molecular sciences·2026
Same author

Why are we still using cisplatin? : Rationale for the continued use of cisplatin in oncology.

Cancer chemotherapy and pharmacology·2026
Same author

Pan-Cancer Analysis of <i>PAPPA</i> Gene Reveals Tumor-Specific Prognostic Effects.

Biology·2026

Related Experiment Video

Updated: Jan 13, 2026

3D Flipwell Engineering for Developing Asynchronous Systems for Toxicologic and Immunomodulatory Therapies in Bacterial, Gut, and Immune Cells
11:00

3D Flipwell Engineering for Developing Asynchronous Systems for Toxicologic and Immunomodulatory Therapies in Bacterial, Gut, and Immune Cells

Published on: October 17, 2025

314

Modulating the microbiome as an approach to anticancer drug development.

Jemma Arakelyan1, Ho-Jung Choe1, Chengnan Wu1

  • 1Department of Chemistry, Drug Discovery Lab, City University of Hong Kong, Hong Kong Special Administrative Region 999077, People's Republic of China.

Proceedings of the National Academy of Sciences of the United States of America
|October 28, 2025
PubMed
Summary

Researchers developed novel gold(I) complexes that selectively target harmful bacteria, sparing beneficial gut microbes. This approach enhances anticancer efficacy and offers a new strategy for microbiome-modulating cancer therapies.

Keywords:
anticancer therapeuticsbioinorganicgold complexmicrobiometumor microenvironment

More Related Videos

Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells
06:07

Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells

Published on: June 13, 2020

7.1K
An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

10.3K

Related Experiment Videos

Last Updated: Jan 13, 2026

3D Flipwell Engineering for Developing Asynchronous Systems for Toxicologic and Immunomodulatory Therapies in Bacterial, Gut, and Immune Cells
11:00

3D Flipwell Engineering for Developing Asynchronous Systems for Toxicologic and Immunomodulatory Therapies in Bacterial, Gut, and Immune Cells

Published on: October 17, 2025

314
Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells
06:07

Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells

Published on: June 13, 2020

7.1K
An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

10.3K

Area of Science:

  • Oncology
  • Microbiology
  • Medicinal Chemistry

Background:

  • The gut microbiome influences cancer patient outcomes and treatment responses.
  • Limited strategies exist for targeted microbiome modulation in cancer therapy.

Purpose of the Study:

  • To identify novel gold(I) complexes with selective antimicrobial activity against non-beneficial bacteria.
  • To evaluate the efficacy of these complexes in modulating the tumor and gut microbiome in vivo.
  • To explore the relationship between microbiome composition, short-chain fatty acid production, and anticancer activity.

Main Methods:

  • In vitro screening of gold(I) complexes for selective bacterial inhibition.
  • In vivo studies in mouse models to assess microbiome changes and anticancer efficacy.
  • Structure-activity relationship analysis of gold(I) complexes.
  • Tumor transcriptomic analysis to identify microbiome-associated signaling pathways.

Main Results:

  • Identified gold(I) complexes selectively inhibited non-beneficial bacteria without harming commensal Lactobacillus strains.
  • The selected gold(I) complex modulated intratumoral and gastrointestinal microbiomes favorably in vivo.
  • Anticancer efficacy correlated with microbiome composition and short-chain fatty acid metabolite production.
  • Structure-activity studies revealed key components for efficacy and microbiome modulation.

Conclusions:

  • Gold(I) complexes represent a promising class of microbiome-modulating agents for cancer therapy.
  • Targeted microbiome modulation can enhance anticancer drug efficacy and potentially reduce side effects.
  • This study provides insights into the mechanism of metal-based chemotherapeutics and their interaction with the microbiome.